Essex Bio-Technology Dirección
Dirección controles de criterios 4/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Haizhou Fang
Chief Executive Officer (CEO)
HK$1.7m
Compensación total
Porcentaje del salario del CEO | 97.5% |
Permanencia del CEO | no data |
Participación del CEO | 0.9% |
Permanencia media de la dirección | 23.8yrs |
Promedio de permanencia en la Junta Directiva | 4.2yrs |
Actualizaciones recientes de la dirección
Recent updates
Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement
Oct 09Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement
May 06Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)
Mar 21Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet
Dec 07Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 07Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04
Aug 25Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?
Jun 22Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055
May 02Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055
Mar 30Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Jun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?
Mar 31If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today
Mar 13How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?
Feb 15Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?
Jan 25Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Jan 04Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 13Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters
Nov 23Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Jun 30 2024 | n/a | n/a | HK$263m |
Mar 31 2024 | n/a | n/a | HK$269m |
Dec 31 2023 | HK$2m | HK$2m | HK$275m |
Sep 30 2023 | n/a | n/a | HK$266m |
Jun 30 2023 | n/a | n/a | HK$256m |
Mar 31 2023 | n/a | n/a | HK$241m |
Dec 31 2022 | HK$2m | HK$2m | HK$225m |
Sep 30 2022 | n/a | n/a | HK$274m |
Jun 30 2022 | n/a | n/a | HK$323m |
Mar 31 2022 | n/a | n/a | HK$334m |
Dec 31 2021 | HK$2m | HK$2m | HK$346m |
Sep 30 2021 | n/a | n/a | HK$339m |
Jun 30 2021 | n/a | n/a | HK$332m |
Mar 31 2021 | n/a | n/a | HK$275m |
Dec 31 2020 | HK$2m | HK$2m | HK$219m |
Sep 30 2020 | n/a | n/a | HK$221m |
Jun 30 2020 | n/a | n/a | HK$222m |
Mar 31 2020 | n/a | n/a | HK$262m |
Dec 31 2019 | HK$2m | HK$737k | HK$303m |
Sep 30 2019 | n/a | n/a | HK$282m |
Jun 30 2019 | n/a | n/a | HK$262m |
Mar 31 2019 | n/a | n/a | HK$246m |
Dec 31 2018 | HK$2m | HK$766k | HK$231m |
Sep 30 2018 | n/a | n/a | HK$210m |
Jun 30 2018 | n/a | n/a | HK$189m |
Mar 31 2018 | n/a | n/a | HK$178m |
Dec 31 2017 | HK$2m | HK$721k | HK$167m |
Compensación vs. Mercado: La compensación total de Haizhou($USD224.31K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD359.96K).
Compensación vs. Ingresos: La compensación de Haizhou ha sido consistente con los resultados de la empresa en el último año.
CEO
Haizhou Fang (58 yo)
no data
Permanencia
HK$1,744,587
Compensación
Mr. Haizhou Fang serves as the Managing Director and Executive Director of Essex Bio-Technology Limited and served as its General Manager. Mr. Fang is qualified as a Senior Pharmaceutical Engineer (Profess...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Founder & Chairman | no data | HK$3.23m | 52.75% HK$ 805.1m | |
MD & Executive Director | no data | HK$1.74m | 0.92% HK$ 14.1m | |
Executive Director & Deputy MD | no data | HK$1.80m | 0.36% HK$ 5.5m | |
Executive Director & Company Secretary | 23.8yrs | HK$755.60k | 0.0081% HK$ 123.8k | |
Group Chief Scientific Officer | 6.6yrs | sin datos | sin datos |
23.8yrs
Permanencia media
60yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 1061 es experimentado (23.8 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Founder & Chairman | no data | HK$3.23m | 52.75% HK$ 805.1m | |
MD & Executive Director | no data | HK$1.74m | 0.92% HK$ 14.1m | |
Executive Director & Deputy MD | 4.2yrs | HK$1.80m | 0.36% HK$ 5.5m | |
Executive Director & Company Secretary | 4.2yrs | HK$755.60k | 0.0081% HK$ 123.8k | |
Independent Non Executive Director | 23.4yrs | HK$250.00k | sin datos | |
Independent Non Executive Director | 20.2yrs | HK$220.00k | sin datos | |
Independent Non-Executive Director | 1.4yrs | HK$128.33k | sin datos |
4.2yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: La junta directiva de 1061 se considera experimentada (4.2 años de antigüedad promedio).